Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793

Watchlist Manager
Luoxin Pharmaceuticals Group Stock Co Ltd Logo
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Watchlist
Price: 5.06 CNY 1.4% Market Closed
Market Cap: ¥5.5B

Wall Street
Price Targets

Price Targets Summary
Luoxin Pharmaceuticals Group Stock Co Ltd

There are no price targets for Luoxin Pharmaceuticals Group Stock Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Luoxin Pharmaceuticals Group Stock Co Ltd Competitors:
Price Targets
IT
Gartner Inc
21% Upside
PAYX
Paychex Inc
17% Upside

Revenue
Forecast

17% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
17% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 10 years the compound annual growth rate for Luoxin Pharmaceuticals Group Stock Co Ltd's revenue is 17%. The projected CAGR for the next 4 years is 31%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Luoxin Pharmaceuticals Group Stock Co Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Luoxin Pharmaceuticals Group Stock Co Ltd's stock price target?
Not Available

Luoxin Pharmaceuticals Group Stock Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Luoxin Pharmaceuticals Group Stock Co Ltd's Revenue forecast?
Projected CAGR
31%

For the last 10 years the compound annual growth rate for Luoxin Pharmaceuticals Group Stock Co Ltd's revenue is 17%. The projected CAGR for the next 4 years is 31%.

Back to Top